Skip to main content
. Author manuscript; available in PMC: 2018 Apr 10.
Published in final edited form as: J Hypertens. 2017 Apr;35(4):822–829. doi: 10.1097/HJH.0000000000001220

Table 5.

Adverse events among those that received study medications

Ergocalciferol (N=43) Placebo (N=45)
Serious Adverse Events
All 0 0
Rash 0 0
Minor Adverse Events
All 6 6
Abdominal discomfort 5 4
Dry Mouth 0 1
Elevated serum phosphorous 0 1
Elevated potassium 1 0